Laser trabeculoplasty for open angle glaucoma

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  Rolim De Moura, Christiane ^a   Paranhos Jr , A ^b   Wormald, R ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

Adrenergic beta antagonists adverse effects; therapeutic use ; Glaucoma, open angle drug therapy; *surgery ; Laser therapy *methods ; Ocular hypertension drug therapy; surgery ; Randomized controlled trials as topic

Indexed keywords

ARGON; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORNEA EDEMA; DISEASE COURSE; EYE DISEASE; EYE SYNECHIA; FORCED EXPIRATORY VOLUME; GLAUCOMA SURGERY; HUMAN; INTERMETHOD COMPARISON; INTRAOCULAR PRESSURE; LASER SURGERY; OPEN ANGLE GLAUCOMA; OPTIC NERVE DISEASE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SYSTEMIC DISEASE; TRABECULECTOMY; TRABECULOPLASTY; TREATMENT FAILURE; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT; YAG LASER;

EID: 44949094406     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003919.pub2     Document Type: Review

References (114)

1. AGIS {published and unpublished data} AGIS (Advanced Glaucoma Intervention Study) Investigators. The advanced glaucoma intervention study, 8: Risk of cataract formation after trabeculectomy. Archives of Ophthalmology 2001;119(12):1771-9.
2. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within treatment groups. American Journal of Ophthalmology 2001;132(3):311-20.
3. Anonymous. The Advanced Glaucoma Intervention Study (AGIS): 3. Baseline characteristics of black and white patients. Ophthalmology 1998;105(7):1137-45.
4. Anonymous. The Advanced Glaucoma Intervention Study (AGIS): 4.Comparison of treatment outcomes within race. Seven-year results. Ophthalmology 1998;105(7):1146-64.
5. Ederer F, Gaasterland DA, Dally LG, Kim J, VanVeldhuisen PC, Blackwell B, et al.The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race. Ten-year results. Ophthalmology 2004;111(4):651-64.
6. Gaasterland DE, Blackwell B, Dally LG, Caprioli, J, Katz LJ, Ederer F, et al.The Advanced Glaucoma Intervention Study (AGIS): 10. Variability among academic glaucoma subspecialists in assessing optic disc notching. Transactions of the American Ophthalmological Society 2001;99:177-85.
7. Schwartz AL, VanVeldhuisen PC, Gaasterland DE, Ederer F, Sullivan EK, Cyrlin MN, et al.The Advanced Glaucoma Intervention Study (AGIS): 5. Encapsulated bleb after initial trabeculectomy. American Journal of Ophthalmology 1999;127(1):8-19.
8. The AGIS Investigators. Advanced Glaucoma Intervention Study (AGIS): 2. Visual field: method of scoring and reliability. Ophthalmology 1994;101(8):1445-55.
9. The AGIS Investigators. The Advanced Glaucoma Intervention Study, 6: effect of cataract on visual field and visual acuity. Archives of Ophthalmology 2000;118(12):1639-52.
10. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 1. Study design and methods, and baseline characteristics of study patients. Controlled Clinical Trials 1994;15(4):299-325.
11. *The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. American Journal of Ophthalmology 2002;134(4): 481-93.
12. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. American Journal of Ophthalmology 2002;134(4):499-512.
13. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. American Journal of Ophthalmology 2000;130(4):429- 40.
14. Bergea 1992 {published data only} Bergea B, Bodin L, Svedbergh B. Primary argon laser trabeculoplasty vs pilocarpine. II: Long-term effects on intraocular pressure and facility of outflow. Study design and additional therapy. Acta Ophthalmologica 1994;72(2):145-54.
15. Bergea B, Bodin L, Svedbergh B. Primary argon laser trabeculoplasty vs pilocarpine. III. Long-term effects on visual fields. Acta Ophthalmologica Scandinavica 1995;73(3):207-215.
16. Bergea B, Bodin L, Svedbergh B. Primary argon laser trabeculoplasty vs pilocarpine IV. Long-term effects on optic nerve head. Acta Ophthalmologica Scandinavica 1995;73(3):216-21.
17. Bergea B, Svedbergh B. Primary argon laser trabeculoplasty vs. pilocarpine. Short-term effects. Acta Ophthalmologica 1992;70(4):454-60.
18. Svedbergh B, Bodin L, Bergea B. Primary argon laser trabeculoplasty versus pilocarpine. Investigative Ophthalmology and Visual Science 1994;35:Abstract 3762.
19. Blyth 1999 {published data only} *Blyth CPJ, Moriarty AP, McHugh JDA. Diode laser trabeculoplasty versus argon laser trabeculoplasty in the control of primary open angle glaucoma. Lasers in Medical Science 1999;14(2):105-8.
20. Moriarty AP, McHugh JD, Ffytche TJ, Marshall JM, Spalton DJ, Moriarty BJ. Diode laser trabeculoplasty (DLT) versus argon laser trabeculoplasty (ALT) in primary open angle glaucoma. American Academy of Ophthalmology 1994:107.
21. Brancato 1991 {published data only} *Brancato R, Carassa R, Trabucchi G. Diode laser compared with argon laser for trabeculoplasty. American Journal of Ophthalmology 1991;112(1):50- 5.
22. Chung 1998 {published data only} Chung PY, Schuman JS, Netland PA, Lloyd-Muhammad RA, Jacobs DS. Five-year results of a randomized, prospective, clinical trial of diode vs argon laser trabeculoplasty for open-angle glaucoma. American Journal of Ophthalmology 1998;126(2):185-90.
23. Damji 1999 {published data only} Damji KF, Bovell AM, Hodge WG, Rock W, Shah K, Buhrman R, Pan I. Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial trabeculoplasty: results from a 1-year randomised clinical trial. British Journal of Ophthalmology 2006;90(12):1490-4.
24. *Damji KF, Shah KC, Rock WJ, Bains HS, Hodge WG. Selective laser trabeculoplasty v argon laser trabeculoplasty: a prospective randomised clinical trial. British Journal of Ophthalmology 1999;83(6):718-22.
25. Hodge WG, Damji KF, Rock W, Buhrmann R, Bovell AM, Pan Y. Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial. British Journal of Ophthalmology 2005;89(9):1157-60.
26. Elsas 1989 {published data only} Elsas T, Johnsen H, Brevik TA. The immediate pressure response to primary laser trabeculoplasty - a comparison of one- and two-stage treatment. Acta Ophthalmologica 1989;67(6):664-8.
27. EMGT {published data only} Heijl A, Leske MC, Bengtsson B, Bengtsson B, Hussein M, Early Manifest Glaucoma Trial Group. Measuring visual field progression in the Early Manifest Glaucoma Trial. Acta Ophthalmologica Scandinavia 2003;81(3):286-93.
28. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression - Results from Early Manifest Glaucoma Trial. Archives of Ophthalmology 2002;120(10):1268-79.
29. Hyman L, Komaroff E, Heijl A, Bengtsson B, Leske MC, Early Manifest Glaucoma Trial Group. Treatment and vision-related quality of life in Early Manifest Glaucoma Trial. Ophthalmology 2005;112(9):1505-13.
30. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E, Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment - The Early Manifest Glaucoma Trial. Archives of Ophthalmology 2003;121(1):48-56.
31. *Leske MC, Heijl A, Hyman L, Bengtsson B. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 1999;106(11):2144- 53.
32. Leske MC, Heijl A, Hyman L, Bengtsson B, Komaroff E. Factors for progression and glaucoma treatment: The Early Manifest Glaucoma Trial. Current Opinion in Ophthalmology 2004;15(2):102-6.
33. Gandolfi 2005 {published data only} Gandolfi S, Chetta A, Cimino K, Mora P, Sangermani C, Tardini G. Bronchial reactivity in healthy individuals undergoing long-term treatment with beta-blockers. Archives of Ophthalmology 2005;123(1):35-8.
34. GLT {published data only} Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial: 4. Contralateral effects of timolol on the intraocular pressure of eyes treated with ALT. Ophthalmic Surgery 1991;22(6):324-9.
35. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT): 3. Design and methods. Controlled Clinical Trials 1991;12(4):504-24.
36. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT): 5. Subgroup differences at enrollment. Ophthalmic Surgery 1993;24(4):232-40.
37. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT): 6. Treatment group differences in visual field changes. American Journal of Ophthalmology 1995;120(1):10-22.
38. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. Ophthalmology 1990;97(11):1403-13.
39. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7. Results. American Journal of Ophthalmology 1995;120(6):718-31.
40. Kiri A, Spaeth G, Beckman H, Sternberg A, GLT Research Group. Optic disc characteristics of blacks and whites in the glaucoma laser trial (GLT). Investigative Ophthalmology and Visual Science 1994;35:Abstract 1187.
41. Sternberg A, Kiri A, Beckman H, Spaeth G, GLT Research Group. Quantitative optic disk characteristics in hypertensive POAG, and diabetic POAG patients in the glaucoma laser trial. Investigative Ophthalmology and Visual Science 1994;35:Abstract 394.
42. Wilensky JT, Beckman H, Meiner CL, Ritch R, Sternberg AL, Glaucoma Laser Trabeculoplasty Study Group. Contribution of each treatment session to IOP reduction resulting from split therapy ALT in the Glaucoma Laser Trial (GLT). Investigative Ophthalmology and Visual Science 1994;35:Abstract 3761.
43. Grayson 1993 {published data only} *Grayson D, Ritch R, Camras C, Lustgarten J, Podos S. Influence of treatment protocol on the long-term efficacy of argon laser trabeculoplasty. Journal of Glaucoma 1993;2(7):7-12.
44. Lustgarten J, Podos S M, Ritch R, Fischer R, Stetz D, Zborowski L, Boas R. Laser trabeculoplasty. A prospective study of treatment variables. Archives of Ophthalmology 1984;102(4):517-9.
45. Grayson 1994 {published data only} Grayson D, Chi T, Liebmann J, Ritch R. Initial argon laser trabeculoplasty to the inferior vs superior half of trabecularmeshwork. Archives of Ophthalmology 1994;112(4):446-7.
46. Hugkulstone 1990 {published data only} Hugkulstone CE. Argon laser trabeculoplasty with standard and long duration. Acta Ophthalmologica 1990;68(5):579-81.
47. Hugkulstone CE. Two-year follow-up of intra-ocular pressure control with long duration argon laser trabeculoplasty. Ophthalmologica 1993;71(3):327-31.
48. Moorfields PTT {published data only} Hitchings R, Migdal C, Fitzke F. Intraocular pressure: does it protect the Visual Fields?. Glaucoma Update IV Berlin Heidelberg. Springer-Verlag, 1991.
49. Hitchings R, Migdal C, Gregory W, Poinooswamy D, Fitzke F. The use of Humphrey Perimeter to identify visual loss. Annual Congress of Royal College of Ophthalmologists. May, 1993.
50. Hitchings R, Migdal C, Wormald R, Poinooswamy D, Fitzke F. The primary treatment trial: Changes in the visual field analysis by computerised-assisted perimetry. Eye 1994;8(Pt 1):117-20.
51. McHam M, Migdal C, Netland P. Early trabeculectomy in the management of primary open angle glaucoma. International Ophthalmology Clinics 1994;34(3):163-72.
52. Migdal C. What is the appropriate treatment for patients with primary open angle glaucoma: medicine, laser or primary surgery. Ophthalmic Surgery 1995;26(2):108-9.
53. Migdal C, Clark P, Hitchings C. Glaucomatous field changes related to the method and the degree of intraocular pressure control. Documenta Ophthalmologica. Vol. 49, 1987:371-6.
54. *Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology 1994;101(10):1651-6.
55. Migdal C, Hitchings R. Control of chronic simple glaucoma with primarymedical, surgical and laser treatment.Transactions of the Ophthalmological Societies of the United Kingdom 1986;105(Pt 6):653-6.
56. Migdal C, Hitchings R. Primary therapy for chronic simple glaucoma the role of argon laser trabeculoplasty. Transactions of the Ophthalmological Societies of the United Kingdom 1984;104(Pt 1):62-6.
57. Migdal C, Hitchings R. The role of early surgery for open angle glaucoma. Ophthalmology Clinics of North America 1991;4(4):853-9.
58. Migdal C, Hitchings R, Gregory M. Effect of mean IOP levels on visual field preservation in treated glaucoma patients. Annual Congress of Royal College of Ophthalmologists. May 1993.
59. Moriarty 1988 {published data only} Moriarty BJ, Char JN, Acheson RW, Dunn DT. Argon laser trabeculoplasty in primary open-angle glaucoma - results in black Jamaican population. International Ophthalmology 1988;12(4):217-21.
60. Rouhiainen 1988 {published data only} Rouhiainen HJ, Terasvirta ME, Tuovinen EJ. Peripheral anterior synechiae formation after trabeculoplasty. Archives of Ophthalmology 1988;106(2):189-91.
61. Rouhiainen HJ, Terasvirta ME, Tuovinen EJ. The effect of some treatment variables on the results of trabeculoplasty. Archives of Ophthalmology 1988;106(5):611-3.
62. Sherwood 1987 {published data only} Sherwood MB, Lattimer J, Hitchings RA. Laser trabeculoplasty as supplementary treatment for primary open angle glaucoma. British Journal of Ophthalmology 1987;71(3):188-91.
63. Smith 1984 {published data only} Smith J. Argon laser trabeculoplasty: comparison of bichromatic and monochromatic wavelengths. Ophthalmology 1984;91(4):355-60.
64. Watson 1984 {published data only} Watson PG, Allen ED, Graham CM, Porter GP, Pickering MS. Argon laser trabeculoplasty or trabeculectomy a prospective randomised block study. Transactions of the Ophthalmological Societies of the United Kingdom 1984;104(Pt 1):55-61.
65. Agarwal 2006 *Agarwal HC, Poovali S, Sihota R, Dada T. Comparative evaluation of diode laser trabeculoplasty vs frequency doubled Nd :YAG laser trabeculoplasty in primary open angle glaucoma. Eye 2006;20:1352-6.
66. Brancato 1988 Brancato R, Menchini U, Pece A, Bandello F, Serini P, Fantaguzzi S. Laser trabeculoplasty: argon laser or krypton laser? [Trabeculoplastie au laser: laser a l'argon ou laser au krypton?]. Ophtalmologie 1988;2(3):221-2.
67. Demailly 1989a Demailly P, Lehrer M, Kretz G. Argon laser trabeculoretraction in normal pressure glaucoma. A prospective study on the tonometric and perimetric effect. Journal Francais d' Ophtalmologie 1989;12(3):183-9.
68. Douglas 1987 Douglas GR, Wijsman K. Effects of laser trabeculoplasty on intraocular pressure in the medically untreated eye. Canadian Journal of Ophthalmology 1987;22(3):157-60.
69. Englert 1997 Englert JA, Cox TA, Allingham RR, Shields MB. Argon vs diode laser trabeculoplasty. American Journal of Ophthalmology 1997;124(5):627-31.
70. Frenkel 1997 Frenkel RE, Shin DH, Epstein DL, Hertzmark E, Bohn JL, Hong YJ. Laser trabeculoplasty: how little is enough. Ophthalmic Surgery & Lasers 1997;28(11):900-4.
71. Heijl 1984 Heijl A. One- and two-session laser trabeculoplasty. A randomized, prospective study. Acta Ophthalmologica 1984;62(5): 715-24.
72. Hollo 1996 Hollo G. Argon and low energy, pulsed Nd:YAG laser trabeculoplasty. A prospective, comparative clinical and morphological study. Acta Ophthalmologica Scandinavica 1996;74(2):126-31.
73. Huk 1991 Huk B, Garus HJ, Bleckmann H. Anti-inflammatory treatment after argon laser trabeculoplasty. Ophthalmologica 1991;203(1): 24-9.
74. Lai 2004 Lai JSM, Chua JKH, Tham CCY, Lam DSC. Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clinical Experimental Ophthalmology 2004;32(4):368-72.
75. Moriarty 1993 Moriarty AP, McHugh JD, Spalton DJ, Ffytche TJ, Shah SM, Marshall J. Comparison of the anterior chamber inflammatory response to diode and argon laser trabeculoplasty using a laser flare meter. Ophthalmology 1993;100(8):1263-7.
76. Nagar 2005 Nagar M, Ogunyomade A, O'Brart DP, Howes F, Marshall J. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. British Journal of Ophthalmology 2005;89(11):1413-7.
77. Popiela 2000 Popiela G, Muzyka M, Szelepin L, Cwirko M, Nizankowska MH. Use of YAG-Selecta laser and argon laser in the treatment of open angle glaucoma [Zastosowanie lasera YAG-Selecta i lasera argonowego w leczeniu jaskry otwartego kata]. Klinica Oczna 2000;102(2):129-33.
78. Shin 1996 Shin DH, Frenkel RE, David R, Cheetham JK. Effect of topical anti-inflammatory treatment on the outcome of laser trabeculoplasty. The Fluorometholone-Laser Trabeculoplasty Study Group. American Journal of Ophthalmology 1996;122(3):349-54.
79. Traverso 1984 Traverso CE, Greenidge KC, Spaeth GL. Formation of peripheral anterior synechiae following argon laser trabeculoplasty. A prospective study to determine relationship to position of laser burns. Archives of Ophthalmology 1984;102(6):861-3.
80. Tuulonen 1989 Tuulonen A, Koponen J, Alanko HI, Airaksinen PJ. Laser trabeculoplasty versus medication treatment as primary therapy for glaucoma. Acta Ophthalmologica 1989;67(3):275-80.
81. Weinreb 1983 Weinreb RN, Ruderman J, Juster R, Zweig K. Immediate intraocular pressure response to argon laser trabeculoplasty. American Journal of Ophthalmology 1983;95(3):279-86.
82. Weinreb 1983a Weinreb RN, Ruderman J, Juster R, Wilensky JT. Influence of the number of laser burns administered on the early results of argon laser trabeculoplasty. American Journal of Ophthalmology 1983;95(3):287-92.
83. Gandolfi 2004a Gandolfi SA, Sangermani C, Cimino L, Ungaro N, Tardini, Viswanathan A, et al. Is there a non IOP related effect of brimonidine on visual field progression in human glaucoma?. Investigative Ophthalmology and Visual Science 2004;45:E abstract 2298.
84. Krasnov 1982 Krasnov MM, Akopian VS, Il'ina TS, Kazakova EL. Laser treatment of primary open-angle glaucoma. Randomized comparative studies. Cyclotrabeculospasis and trabeculoplasty. Vestnik Oftalmologii 1982;5:18-22.
85. Schrems 1988 Schrems W, Hofmann G, Krieglstein GK. Therapy of open-angle glaucoma with the argon and neodymium laser. Fortschritte der Ophthalmologie 1988;85(1):119-23.
86. Bathija 1998 Bathija R, Gupta N, Zangwill L, Weinreb RN. Changing definition of glaucoma. Journal of Glaucoma 1998;7(3):165-9.
87. Bonomi 1998 Bonomi L, Marchini G, Marraffa M, Bernardi P, De Franco I, Perfetti S, et al.Prevalence of glaucoma and intraocular pressure distribution in a defined population. The Egna-Neumarkt Study. Ophthalmology 1998;105(2):209-15.
88. Buhrmann 2000 Buhrmann RR, Quigley HA, Barron Y, West SK, Oliva MS, Mmbaga BB. Prevalence of glaucoma in a rural East African population. Investigative Ophthalmology and Visual Science 2000;41(1):40-8.
89. Cedrone 1997 Cedrone C, Culasso F, Cesareo M, Zapelloni A, Cedrone P, Cerulli L. Prevalence of glaucoma in Ponza, Italy: a comparison with other studies. Ophthalmic Epidemiology 1997;4(2):59-72.
90. Dielemans 1994 Dielemans I, Vingerling JR, Wolfs RC, Hofman A, Grobbee DE, de Jong PT. The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology 1994;101(11):1851-5.
91. Glanville 2006 Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
92. Higgins 2006 Higgins JPT, Green S, editors. Assessment of study quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006] Section 6. In: The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd.
93. Hyman 2001 Hyman L, Wu SY, Connell AM, Schachat A, Nemesure B, Hennis A, et al.Prevalence and causes of visual impairment in The Barbados Eye Study. Ophthalmology 2001;108(10):1751-6.
94. Kim 2000 Kim YJ, Moon CS. One-year follow-up of laser trabeculoplasty using Q-switched frequency-doubled Nd:YAG laser of 523 nm wavelength. Ophthalmic Surgery and Lasers 2000;31(5):394-9.
95. Krasnov 1973 Krasnov MM. Laseropuncture of anterior chamber angle in glaucoma. American Journal of Ophthalmology 1973;75(4):674-8.
96. Lanzetta 1999 Lanzetta P, Menchini U, Virgili G. Immediate intraocular pressure response to selective laser trabeculoplasty. British Journal of Ophthalmology 1999;83(1):29-32.
97. Latina 1998 Latina MA, Sibayan SA, Shin DH, Noecker RJ, Marcellino G. Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study. Ophthalmology 1998;105(11):2082-8; discussion 2089-90.
98. Leske 1983 Leske MC. The epidemiology of open-angle glaucoma: a review. American Journal of Epidemiology 1983;118(2):166-91.
99. Leske 1994 Leske MC, Connell AM, Schachat AP, Hyman L. The Barbados Eye Study. Prevalence of open angle glaucoma. Archives of Ophthalmology 1994;112(6):821-9.
100. Maier 2005 Maier PC, Funk J, Schwarzer G, Antes G, Fal k-Ytter YT. Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials. BMJ 2005;331(7509):134-9.
101. Mason 1989 Mason RP, Kosoko O, Wilson MR, Martone JF, Cowan CLJ, Gear JC, et al.National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I. Prevalence findings. Ophthalmology 1989;96(9):1363-8.
102. Quigley 2006 Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology 2006;90(3):262-7.
103. Realini 2002 Realini T, Fechtner RD. 56,000 ways to treat glaucoma. Ophthalmology 2002;109(11):1955-6.
104. Schwartz 1985 Schwartz AL, Love DC, Schwartz MA. Long-term follow-up of argon laser trabeculoplasty for uncontrolled open-angle glaucoma. Archives of Ophthalmology 1985;103(10):1482-4.
105. Shields 2005 Allingham RR, Damji KF, Freedman S, Moroi SE, Shafranov G, Shields MB. Shields' Textbook of Glaucoma. 5th Edition. Philadelphia: Lippinicott Williams & Wilkins, 2005.
106. Thylefors 1994 Thylefors B, Negrel AD. The global impact of glaucoma. Bulletin of the World Health Organization 1994;72(3): 323-6.
107. Tielsch 1991 Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 1991;266(3):369-74.
108. Traverso 1986 Traverso CE, Spaeth GL, Starita RJ, Fellman RL, Greenidge KC, Poryzees E. Factors affecting the results of argon laser trabeculoplasty in open-angle glaucoma. Ophthalmic Surgery 1986;17(9):554-9.
109. Vass 2007 Vass C, Hirn C, Sycha T, Findl O, Bauer P, Schmetterer L. Medical interventions for primary open angle glaucoma and ocular hypertension. Cochrane Database of Systematic Reviews 2007, Issue 4.Art. No.: CD003167. DOI:10.1002/14651858.CD003167.pub2.
110. Wensor 1998 Wensor MD, McCarty CA, Stanislavsky YL, Livingston PM, Taylor HR. The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology 1998;105(4):733-9.
111. Wilkins 2005 Wilkins M, Indar A, Wormald R. Intra-operative mitomycin C for glaucoma surgery. Cochrane Database of Systematic Reviews 2005, Issue 4.Art. No.: CD002897. DOI:10.1002/14651858.CD002897.pub2..
112. Wise 1979 Wise JB, Witter SL. Argon laser therapy for open-angle glaucoma. A pilot study. Archives of Ophthalmology 1979;97(2):319- 22.
113. Wolfs 2000 Wolfs RC, Borger PH, Ramrattan RS, Klaver CC, Hulsman CA, Hofman A, et al.Changing views on open-angle glaucoma: definitions and prevalences - The Rotterdam Study. Investigative Ophthalmology and Visual Science 2000;41(11):3309-21.
114. Worthen 1974 Worthen DM, Wickham MG. Argon laser trabeculotomy. Transactions of the American Academy of Ophthalmology 1974;78:371-5.